Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.8K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.2K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.2K
Prevalence and Incidence01:08

Prevalence and Incidence

1.9K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

844
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
844

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
Same author

Trends in hospitalizations in adults with HIV infection in Spain over 25 years.

Pathogens and global health·2026
Same author

Infection With Human T-Lymphotropic Virus 1 (HTLV-1) in Ivory Coast.

Journal of medical virology·2026
Same author

HTLV-1 genetic diversity of 52 complete sequences from 14 African countries reveals novel variants and a lack of typical P12/P8 and P30 accessory proteins in HTLV-1b, d, and f genotypes.

Emerging microbes & infections·2026
Same author

Is the HIV-2 pandemic vanishing?

AIDS reviews·2025
Same author

The cascade of care for hepatitis B - any lessons from the HIV field?

Expert review of anti-infective therapy·2025

Related Experiment Video

Updated: Feb 16, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.3K

HIV Epidemics - Current Burden and Future Prospects.

Carmen de Mendoza1

  • 1Puerta de Hierro Research Institute, Majadahonda, Spain.

AIDS Reviews
|December 23, 2017
PubMed
Summary
This summary is machine-generated.

Despite progress, 37 million live with HIV globally, with 2 million new infections annually. Antiretroviral therapy and new genetic strategies offer hope for an HIV/AIDS-free world, but challenges remain.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K

Related Experiment Videos

Last Updated: Feb 16, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.3K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

32.2K

Area of Science:

  • Global Health
  • Infectious Diseases
  • Virology

Background:

  • The World Health Organization estimates nearly 37 million people were living with HIV globally by the end of 2016, with approximately 20 million receiving antiretroviral therapy.
  • Despite advancements, nearly 2 million new HIV infections occur annually, with significant regional variations in transmission dynamics (e.g., men who have sex with men in North America/EU, heterosexual women in Sub-Saharan Africa, injection drug use in Asia).

Purpose of the Study:

  • To review the current global status of HIV epidemics, treatment paradigms, and emerging strategies for HIV cure and prevention.
  • To highlight persistent challenges in HIV/AIDS control and the need for intensified global efforts.

Main Methods:

  • Analysis of updated figures from the World Health Organization (WHO) and UNAIDS on HIV prevalence, incidence, and treatment.
  • Review of current treatment strategies, including lifelong antiretroviral therapy and pre-exposure prophylaxis (PrEP).
  • Exploration of novel genetic strategies, such as CRISPR, for HIV cure and discussion of associated public health concerns like declining condom use and rising sexually transmitted infections.

Main Results:

  • A plateau in HIV epidemics may have been reached, but significant gaps persist in access to antiretroviral therapy, diagnosis, and prevention interventions.
  • Antiretroviral therapy remains crucial for managing HIV, preventing clinical progression, and reducing transmission, with PrEP offering additional prevention benefits.
  • Emerging genetic strategies targeting HIV reservoirs show promise for a potential cure, representing a significant hope for controlling the pandemic.

Conclusions:

  • While progress has been made, a concerted global effort is essential to achieve an HIV/AIDS-free world.
  • Addressing critical gaps in access to care, diagnosis, education, and prevention is paramount to controlling and ultimately eliminating HIV.
  • Continued research into novel therapeutic and preventative strategies, alongside robust public health interventions, is necessary to combat the ongoing HIV epidemic.